Figueroa MI, Brites C, Cecchini D, Ramalho A, et al. Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study. Clin Infect Dis 2025 Aug 28:ciaf415. doi: 10.1093.
PMID: 40874763